The global healthcare industry experienced an 11% drop in social media posts in Q1 2023 compared with the previous quarter, according to GlobalData’s analysis of social media posts. GlobalData’s Pharma Pricing and Reimbursement (P&R) and Market Access Risk report provides a global outlook of the pharmaceutical industry and the unique market access risk scores (MARS) to assess risk and opportunities around the world. Buy the report here.
Notably, the total number of social media posts decreased from 227,109 in Q4 2022 to 201,712 in Q1 2023.
For further understanding of GlobalData's Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) by Region, buy the report here.